VIP specifications and research profile
Specifications summary
| Designation | Vasoactive intestinal peptide; secretin-family neuropeptide |
|---|---|
| Also known as | VIP |
| Sequence / composition | 28-amino-acid vasoactive intestinal peptide |
| Strength | 10mg × 10 vials |
| Presentation | 10-vial case |
| Purity | 99%+ HPLC |
| Storage | Store refrigerated at 2-8 C, protected from light. |
| COA | Batch document added when available |
Description and research context
VIP is a 28-amino-acid member of the secretin peptide family. It serves as an endogenous ligand reference for VPAC1 and VPAC2 class-B G-protein-coupled receptors.
Receptor and cell-based studies measure ligand binding, adenylate-cyclase activation and intracellular cAMP responses, often alongside PACAP comparators. Results depend on receptor subtype and expression system.
Applications in research
- VPAC1 and VPAC2 binding assays
- Adenylate-cyclase and cAMP-response measurements
- VIP-versus-PACAP receptor-selectivity comparisons
Precautions and interpretation
For controlled laboratory research only. Not for human or veterinary use. The cited findings come from specific biochemical, cellular, structural or preclinical models and must not be treated as usage guidance or evidence of a defined outcome outside those models.
Research references
VIP research record
Clear product, batch, storage, dispatch and document information for this 10-vial case.
Research context
Vasoactive intestinal peptide is a 28-amino-acid secretin-family peptide studied in VPAC1/VPAC2 receptor binding and cAMP-signalling models.
Product record
The listing identifies the presentation, specification, storage record, dispatch status, and COA availability for the relevant product or batch.
Use restriction
For laboratory research use only. Not for human or veterinary consumption. No use instructions or therapeutic guidance is provided.